Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127094) titled 'Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Aya Mohammed Abdel Magid Abdel Hamid
Condition:
Bioequivalence Study in Healthy Subjects
Intervention:
Drug: Test Product (Glimcoza)
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March 9, 2025
Target Sample Size: 29
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials....